FdaApplication
ANDA 213244
Identifiers
- fda_app_no: ANDA213244
Properties
| Property | Value |
|---|---|
| applicant_name | EUGIA PHARMA SPECIALITIES LTD |
| application_type | ANDA |
| approval_date | 2023-11-02 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION;INTRAVENOUS |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 5MG/10ML(0.5MG/ML) | INJECTABLE;INJECTION |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION;INTRAVENOUS |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 10MG/10ML(1MG/ML) | INJECTABLE;INJECTION |
4 products